Interní Med. 2005; 7(3): 139-140

Excessive daytime sleepiness and its symptomatic treatment

doc. MUDr. Karel Šonka DrSc
Neurologická klinika 1. LF UK a VFN, Praha

Excessive daytime sleepiness occurs in about 5% of the population. It is provoked by primary hypersomnias, of which narcolepsy is the most important, and also by diseases involving disturbed nocturnal sleep (obstructive sleep apnoea, restless legs syndrome, periodic limb movements in sleep), some other neurological affections (Parkinson´s disease, multiple sclerosis, Alzheimer´s disease and encephalitis) and by diseases with reduced nocturnal sleep duration (insomnia, shiftwork intolerance and sleep insufficiency). A historical and recent overview of symptomatic therapy of excessive daytime sleepiness. Two drugs are currently used in the CR – methylphenidate and modafinil.

Keywords: Key words: excessive daytime sleepiness, hypersomnia, wakefulness promoting drugs, narcolepsy, methylphenidate, modafinil.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šonka K. Excessive daytime sleepiness and its symptomatic treatment. Interní Med. 2005;7(3):139-140.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adler CH, Caviness JN, Hentz JG, Lind M, Tede J. Randomized trial of modafinil for treating subjective daytime sleepiness in patiens with Parkinson´s disease. Mov Disord 2003; 18: 287-293. Go to original source... Go to PubMed...
    2. Bareš M, Kaňovský P, Rektor I. Excessive daytime sleepiness and sleep attacks induced by entacapone. Fund Clin Pharmacol 2003; 17: 113-116. Go to original source... Go to PubMed...
    3. Bastuji H, Jouvet M. Succesful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry, 1988; 12: 695-700. Go to original source... Go to PubMed...
    4. Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S. Modafinil: a double-blind multicentric study. Sleep, 1994; 17: S107-S112. Go to original source... Go to PubMed...
    5. Boutrel B, Koob GF. What keeps us awake: the neuropharmacology of stimulans and wakefulness-promoting medications. Sleep 2004; 27: 1181-1194. Go to original source... Go to PubMed...
    6. Broughton RJ, Fleming JAE, George CFP, Hill JD, Kryger MH, Moldofsky H, Montplaisir JY, Morehouse RL, Moscovitch A, Murphy WF. Randomised, double blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology, 1997; 49: 444-451. Go to original source... Go to PubMed...
    7. DeBattista C, Doghramji K, Menza MA, Rosenthal MH, Fieve RR. Adjunkt modafinil for the short-term treatment of fatigue and sleepiness in patiens with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003; 64: 1057-1064. Go to original source... Go to PubMed...
    8. Doyle JB, Daniels LE. Symptomatic treatment for narcolepsy. J Amer Med Ass 1931; 9: 1370-1372. Go to original source...
    9. Jakoubková M, Šonka K, Roth J, Růžička E, Michalčíková B, Jech R, Mečíř P, Nevšímalová S. Spánek při Parkinsonově nemoci - dotazníkové šetření. Čes a Slov Neurol Neurochir 2001; 64/97: 268-272.
    10. Janota O. Discussion of a paper by Pelnář: Narkolepsie avec cataplexie. Rev Neurol (Paris) 1930; 47: 427-428.
    11. Lundt L. Modafinil treatment in patiens with seasonal affective disorder/winter depression: an open-label pilot study. J Affect Disord 2004; 81: 173-178. Go to original source... Go to PubMed...
    12. Nevšímalová S. Nadměrná denní spavost. In: Nevšímalová S, Šonka K, eds. Poruchy spánku a bdění. Praha: Maxdorf, 1997; 99-120.
    13. Pack AI, Blafl JE, Schwarz JRL, Matheson JK for the U.S. Modafinil in Obstructive Sleep Apnea Study Group. Modafinil as adjunkt therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164: 1675-1681. Go to original source... Go to PubMed...
    14. Prinzmetall M, Bloomberg W. The use of benzedrine for the treatment of narcolepsy. J Amer Med Ass 1935; 105: 2051-2054. Go to original source...
    15. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002; 72: 179-183. Go to original source... Go to PubMed...
    16. Roth B. Narcolepsy and hypersomnia. Avicenum, Praha 1980: 1-310.
    17. Šonka K. Poruchy spánku. In: Nevšímalová S, Růžička E, Tichý J, eds. Neurologie. Praha: Galén, 2002: 227-234.
    18. Šonka K, ed. Apnoe a další poruchy dýchání ve spánku. Praha: Grada - Avicenum, 2004: 1-247.
    19. Šonka K, Kemlink D. Restless legs syndrome in 2004. Prague Medical Report 2004; 105: 337-356.
    20. US Modafinil in Narcolepsy Multicenter Study Group. Randomized Trial of Modafinil for the Treatment of Pathological Somnolence in Narcolepsy. Ann Neurol, 1998; 43: 88-97. Go to original source... Go to PubMed...
    21. Yoss RE, Daly DD. Treatment of narcolepsy with Ritalin. Neurology 1959; 9: 171-173. Go to original source... Go to PubMed...
    22. Webster L, Andrews M, Stoddard G. Modafinil treatment of opioid-induced sedation. Pain Med 2003; 4: 135-140. Go to original source... Go to PubMed...
    23. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis. J Neurol 2002; 249: 983-987. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.